Harvoni Tablet 90 Mg+400 Mg: Ledipasvir and Sofosbuvir

A branded medicine used to manage chronic hepatitis C. This formulation combines ledipasvir and sofosbuvir, which work together to stop the virus from multiplying within your liver cells.

What Is Harvoni Tablet 90 Mg+400 Mg?

Harvoni Tablet 90 Mg+400 Mg is a fixed-dose combination therapy containing the active compounds ledipasvir and sofosbuvir. As a branded formulation, it is widely recognized for its high efficacy in the care of individuals living with chronic hepatitis C. It serves as a direct-acting antiviral, meaning the medication targets specific proteins required by the hepatitis C virus to survive and duplicate.

Gilead Sciences, Inc. manufactures this specific formulation. By combining two complementary antiviral agents, the product is designed to inhibit different stages of the viral life cycle. This approach has transformed how chronic hepatitis C is addressed, focusing on clearing the virus from your bloodstream effectively.

How Is Harvoni Tablet 90 Mg+400 Mg Classified?

Across regulated markets including the United States, United Kingdom, Australia, and Canada, medicines containing ledipasvir and sofosbuvir are strictly classified as prescription-only medications. This classification ensures that you receive medical supervision, as the use of this antiviral requires an evaluation of your liver function and specific viral genotype.

While the fundamental regulatory status remains consistent across these regions, local healthcare systems often have specific guidelines regarding how this therapy is accessed through public health schemes or private pharmacy channels. Requirements such as initial specialist approval or specific diagnostic testing for your viral load may vary based on local clinical protocols.

Harvoni Tablet 90 Mg+400 Mg: Form and Available Strengths

Harvoni Tablet 90 Mg+400 Mg is prepared as an oral tablet. Each tablet is formulated with a fixed concentration of 90 mg of ledipasvir and 400 mg of sofosbuvir. These strengths are balanced to ensure the compounds work consistently throughout the duration of your treatment plan.

The tablets are intended for daily administration. Because this is a branded medicine developed for specific therapeutic regimens, the dosage strength is standardized to simplify your routine and ensure you maintain the necessary concentration of the medication in your system.

What Is Harvoni Tablet 90 Mg+400 Mg Used For?

This medication is used to manage chronic hepatitis C virus (HCV) infection. It targets specific genotypes of the virus, helping to clear the infection from your body. By reducing the amount of the virus in your blood, the treatment assists with preventing long-term damage like cirrhosis or liver scarring.

Many people use this therapy to achieve a sustained virologic response, which means the virus is no longer detectable in your blood after you complete your course. It is an essential component in modern antiviral care, designed for patients who need a highly effective, once-daily option to address their chronic infection.

How Do Ledipasvir and Sofosbuvir Work in Harvoni Tablet 90 Mg+400 Mg?

Think of the hepatitis C virus as a tiny, efficient factory that needs specific tools to build more copies of itself. Your liver is where this factory sets up shop, and ledipasvir and sofosbuvir act as two different types of roadblocks to shut that operation down. Ledipasvir interferes with a protein the virus needs to assemble new viral particles, while sofosbuvir tricks the virus into using a faulty building block when it tries to copy its own genetic code.

Because the virus can’t make functional copies without these two processes, it eventually dies off and can no longer infect healthy liver cells. Once the replication slows down, your immune system has a much easier time clearing out the remaining virus. This dual-action approach is why these two compounds are so effective at clearing the infection when taken as directed over several weeks.

Where Harvoni Tablet 90 Mg+400 Mg Fits in Its Drug Class

This medicine belongs to a class known as direct-acting antivirals (DAAs). Unlike older, non-specific therapies that often caused widespread fatigue throughout your body, DAAs are designed to hit the virus exactly where it works. This class has replaced older interferon-based treatments for most individuals, offering a more targeted and generally better-tolerated experience.

Because this combination includes two different mechanisms, it is often more robust than using a single antiviral agent. Other options, such as sofosbuvir/velpatasvir or glecaprevir/pibrentasvir, also fall into this modern category of antiviral therapy. These medications focus on different genotypes of the virus, allowing providers to tailor the approach based on the specific strain identified in your bloodstream.

Safety Overview for Harvoni Tablet 90 Mg+400 Mg

What to check before using this medicine

Before you start this therapy, it is necessary to confirm your specific viral genotype to ensure the medicine is appropriate for your infection. Inform your provider if you have any existing liver conditions, such as hepatitis B, because the medication can reactivate dormant viruses in some cases. Additionally, mention any history of kidney function issues or if you are planning to become pregnant, as these factors influence how your body handles the compounds.

Possible reactions and tolerability

Many people tolerate this antiviral treatment well, though you might notice common occurrences like fatigue or headache as your body adjusts to the active compounds. These effects are usually mild and do not require your treatment to stop. If you experience unexpected changes in your mood, digestion, or energy levels, keep track of them and discuss these patterns with a professional.

Interactions and health factors

Your liver and kidneys are the primary organs that process these compounds, so other medications you take can affect the concentration of the antivirals in your blood. Be sure to provide a full list of all supplements, herbal products, and prescription drugs you use to avoid unwanted interactions. Product labeling and verified clinical sources remain the correct references for specific contraindications, interactions, and potential reactions.

Finding Harvoni Tablet 90 Mg+400 Mg Online

• Patients in the United States, United Kingdom, Australia, Canada, and similar markets search for this medication through online pharmacy directories and health platforms before speaking with a local provider.
• You may find people comparing the branded version to generic equivalents containing the same active compounds to understand their options.
• Many searchers look for listings of the 90 mg/400 mg strength to identify which pharmacies provide access to their specific regimen.
• Searching online often helps you identify availability before or during transitions, such as relocating to a new region or checking what is currently supported by your local pharmacy.

Important Safety Information for Harvoni Tablet 90 Mg+400 Mg

Harvoni Tablet 90 Mg+400 Mg contains ledipasvir and sofosbuvir, which function as targeted antiviral agents for chronic hepatitis C. Products containing these compounds may differ in formulation, strength, and specific usage directions. This page is for educational purposes and does not authorize clinical application, self-directed interpretation, or unsupervised use of the product. Readers should review the official product labeling, compare it with their own health situation, and consult a healthcare professional for all decisions requiring clinical judgment.